5-BROMO-6-METHOXY-1-METHYL-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 1g

1-Cyclopropyl-2,2,2-trifluoro-ethanone, 90.0%, 250mg

N-(4-BROMO-2-CHLOROPHENYL)-3-CHLOROPROPANAMIDE, 95.0%, 1g

(3,5-Dimethyl-pyrazol-1-yl)-acetic acid, 99.0%, 100g

LOMITAPIDE, 95%, 250mg

(2E)-3-[4-(benzyloxy)phenyl]-1-(3,4-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

2-Bromo-4-phenylquinazoline, 98+%, 5g

1,2:5,6-Di-o-isopropylidene-alpha-D-allofuranose, 95.0%, 25g

(2R,3S)-2-(4-(cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid, 97%, 1g

(1H-Pyrrolo[2,3-b]pyridin-3-yl)methanol, 95.0%, 1g

Ethyl 3-methylpyrrolidine-3-carboxylate hydrochloride, 98%, 5g

3-Chloromethyl-5-(2-chloro-phenyl)-[1,2,4]oxadiazole, 95.0%, 500mg

(eta7-Cycloheptatrienyl)(eta5-cyclopentadienyl)titanium(II)>95.0%(T)100mg